Tiedemann Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-25,000
Closed -$547K – 306
2021
Q2
$547K Hold
25,000
– – 0.02% 226
2021
Q1
$513K Hold
25,000
– – 0.02% 210
2020
Q4
$544K Hold
25,000
– – 0.03% 201
2020
Q3
$512K Buy
+25,000
New +$505K 0.02% 226

Other funds holding BCAT

Tiedemann Advisors's BCAT Position: Q3 2021 in Review

Tiedemann Advisors sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2021, closing a stake of 25,000 shares — an estimated $547K sold.

Tiedemann Advisors first reported a position in BCAT in Q3 2020 and held it in 4 quarters. The position peaked at $547K in Q2 2021. 38 funds tracked by Wall St. Rank hold BCAT as of Q3 2021.

  • Tiedemann Advisors reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2021 after selling out during the quarter.
  • Tiedemann Advisors sold 25,000 BlackRock Capital Allocation Term Trust shares in Q3 2021, an estimated $547K.
  • Tiedemann Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q3 2020 and held it in 4 quarters.
  • Tiedemann Advisors's BlackRock Capital Allocation Term Trust position peaked at $547K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2021.

Based on Tiedemann Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.